STOCK TITAN

Medtronic plc (NYSE: MDT) awards RSUs, PSUs and 45,070 options to EVP

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Medtronic plc reported that EVP, GC and Secretary Michelle Quinn received multiple equity awards on 2026-08-03. She was granted 6,346 restricted stock units that vest in full on the third anniversary of grant and now holds 26,721 ordinary shares directly. She also received 15,863 performance share units, which can result in between 0 and 38,071 ordinary shares based on performance through April 27, 2029, and 45,070 stock options with an exercise price of 86.6800 per share, vesting 25% annually and expiring on August 3, 2036.

Positive

  • None.

Negative

  • None.
Insider Quinn Michelle
Role EVP, GC and Secretary
Type Security Shares Price Value
Grant/Award Performance Share Units F2, F3, F4 15,863 $0.00 $0.00
Grant/Award Stock Option (Right to Buy) F5 45,070 $0.00 $0.00
Grant/Award Ordinary Shares F1 6,346 $0.00 $0.00
Holdings After Transaction: Performance Share Units — 15,863 shares (Direct); Stock Option (Right to Buy) — 45,070 shares (Direct); Ordinary Shares — 26,721 shares (Direct)
Footnotes (5)
  1. F1. Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
  2. F2. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
  3. F3. Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
  4. F4. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,863 shares will be issued. If maximum performance metrics are achieved, 38,071 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
  5. F5. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Restricted stock units granted 6,346 units Ordinary-share RSUs granted to Michelle Quinn on 2026-08-03; vest 100% on third anniversary
Performance share units granted 15,863 units PSUs granted 2026-08-03; target payout in ordinary shares if performance metrics are met by 2029-04-27
Maximum shares under PSUs 38,071 shares Maximum ordinary shares issuable if maximum performance metrics are achieved for the PSUs
Stock options granted 45,070 options Options on ordinary shares granted 2026-08-03; vest 25% per year from first anniversary; expire 2036-08-03
Option exercise price 86.6800 per share Exercise price for the 45,070 stock options granted to Michelle Quinn
Ordinary shares held after grant 26,721 shares Direct Medtronic ordinary shares held by Michelle Quinn following the 6,346-unit RSU grant
Performance Share Units financial
"Represents performance share units for which certain performance conditions will have been satisfied"
Performance share units are a type of company stock award given to employees that depend on the company meeting specific goals or targets. If these goals are achieved, the employee receives shares or the value of shares; if not, they may receive little or no compensation. This aligns employees’ interests with the company's success and encourages performance that benefits investors.
restricted stock units financial
"Represents restricted stock units that vest 100% on the third anniversary of the date of grant"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price and expiration date"
exercise price financial
"These options become exercisable at the rate of 25% of the shares granted per year"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
performance metrics financial
"will vary depending on the level of certain performance metrics achieved over a three (3) year"
Performance metrics are concrete numbers or ratios that show how well a business, product, or investment is doing—like speed, fuel use and mileage on a car’s dashboard. They measure things investors care about, such as sales growth, profitability, cash flow, customer retention or efficiency, so readers can compare progress, spot strengths or problems, and make informed decisions about buying, holding or selling shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What equity awards did Medtronic (MDT) grant to EVP Michelle Quinn?

Medtronic granted Michelle Quinn 6,346 restricted stock units, 15,863 performance share units, and 45,070 stock options. The awards were made on August 3, 2026, as part of her executive compensation in Medtronic ordinary shares and related equity instruments.

How do the performance share units granted to Medtronic (MDT) EVP Michelle Quinn work?

Each performance share unit is a contingent right to receive one ordinary share. Depending on performance over a three-year period, Quinn may receive from 0 up to 38,071 shares, with 15,863 shares delivered if target performance metrics are achieved by April 27, 2029.

What are the terms of Michelle Quinn’s Medtronic (MDT) stock options?

Quinn received 45,070 stock options with an exercise price of 86.6800 per share. These options vest at 25% per year beginning on the first anniversary of grant and expire on August 3, 2036, if not exercised earlier.

When do Michelle Quinn’s Medtronic (MDT) restricted stock units vest?

The 6,346 restricted stock units granted to Michelle Quinn vest 100% on the third anniversary of the August 3, 2026 grant date. Upon vesting, they convert into Medtronic ordinary shares, increasing her directly held share position at that time.

How many Medtronic (MDT) ordinary shares does Michelle Quinn hold after these grants?

Following the August 3, 2026 grant of 6,346 restricted stock units, Michelle Quinn directly holds 26,721 ordinary shares. This figure reflects her direct ownership after the reported equity awards, separate from the newly granted options and performance share units.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Quinn Michelle

(Last)(First)(Middle)
710 MEDTRONIC PARKWAY

(Street)
MINNEAPOLIS MINNESOTA 55432

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, GC and Secretary
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares08/03/2026A6,346(1)A$026,721D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Share Units(2)08/03/2026A15,863 (3) (3)Ordinary Shares15,863(4)$015,863D
Stock Option (Right to Buy)$86.6808/03/2026A45,070 (5)08/03/2036Ordinary Shares45,070$045,070D
Explanation of Responses:
1. Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
2. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
3. Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
4. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 15,863 shares will be issued. If maximum performance metrics are achieved, 38,071 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
5. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Remarks:
/s/ Patricia Walesiewicz, attorney-in-fact08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)